

Alkermes is a biotechnology company that develops, manufactures and commercializes medicines for the treatment of chronic diseases. Among its major competitors, Alkermes is ranked in 1st place for NPS while Alnylam Pharmaceuticals is 2nd, and Biogen is 3rd. Overall, Alkermes has a neutral social sentiment, when analyzing social media channels and online mentions.Their current market cap is $3.05B
Alkermes's Net Promoter Score (NPS) is a 47 with 60% Promoters, 27% Passives, and 13% Detractors. Net Promoter Score tracks whether Alkermes's customers would recommend using the product based on a scale of -100 to 100.
| 60% | Promoters |
|---|---|
| 27% | Passives |
| 13% | Detractors |
| Summary | Date | Score |
|---|---|---|
Jul 2021 50 | Jul 2021 | 50 |
Aug 2021 33 | Aug 2021 | 33 |
Feb 2022 50 | Feb 2022 | 50 |
Jul 2022 60 | Jul 2022 | 60 |
Jan 2023 66 | Jan 2023 | 66 |
Apr 2023 55 | Apr 2023 | 55 |
May 2023 60 | May 2023 | 60 |
Jul 2023 63 | Jul 2023 | 63 |
Jul 2024 67 | Jul 2024 | 67 |
Oct 2024 62 | Oct 2024 | 62 |
Sep 2025 50 | Sep 2025 | 50 |
Dec 2025 47 | Dec 2025 | 47 |
Alkermes is ranked first for NPS among its competitors. Alnylam Pharmaceuticals and Biogen come in second and third, with MyoKardia coming in at #4. Among those competitors, it is the lowest valued company behind Biogen.
![]() Alkermes | ![]() Biogen | ![]() Alnylam Pharmaceuticals | ![]() MyoKardia | |
| Global Ranking | #- | #388 | #- | #- |
| NPS | 47 | 21 | 24 | - |
| Social Sentiment Calculated by analyzing social media and other online mentions | Neutral | Neutral | Neutral | Neutral |
| Valuation Updated every 24 hours for public companies | $3.05B | $42.46B | $24.72B | $11.99B |
Net Promoter Score (NPS) is a management tool that can be used to gauge the satisfaction of a firm's customer relationships. NPS has been widely adopted as a key metric often linked to the revenue potential of a company’s product or service. The metric is based on customer responses to the question: "On a scale of 0 to 10, how likely are you to recommend the product to a friend?"
Those who respond with a score of 9 to 10 are known as Promoters, and are widely associated with behaviors that create value, including actively encouraging others to use the product or service. Those who respond with a score of 7 or 8 are categorized as Passives, and they are believed to be less likely to exhibit the value-creation traits of Promoters having a largely neutral effect on other consumers. Detractors are those who fall in the score range of 0 to 6 and represent dissatisfied customers of the product sometimes actively recommending against using the product.
Compared to its competitors, Alkermes's NPS is rated right above Alnylam Pharmaceuticals.
| COMPANY | NPS Score | |
|---|---|---|
![]() | Alkermes | 47 |
![]() | Alnylam Pharmaceuticals | 24 |
![]() | Biogen | 21 |
![]() | Sunovion Pharmaceuticals | 0 |
![]() | MyoKardia | N/A |
![]() | Reata Pharmaceuticals | N/A |
![]() | TESARO | N/A |
![]() | Shire | N/A |
Customer Loyalty is a strong indicator of whether or not a customer will choose a brand repeatedly over a competitor that offers similar products/services.
64% of Alkermes users/customers answered "Yes" when asked: "Would you consider yourself a loyal user/customer?"
Sign Up to see the full customer demographics data and the people that answered "Yes" when asked "Would you consider yourself a loyal user/customer?"
Compared to its competitors, Alkermes's Customer Loyalty score is rated right above Reata Pharmaceuticals, and is preceded by Biogen.
| COMPANY | Customer Loyalty Score | |
|---|---|---|
![]() | Sunovion Pharmaceuticals | 100% |
![]() | MyoKardia | 100% |
![]() | Alnylam Pharmaceuticals | 85% |
![]() | Biogen | 75% |
![]() | Alkermes | 64% |
![]() | Reata Pharmaceuticals | N/A |
![]() | TESARO | N/A |
![]() | Shire | N/A |
Alkermes has an overall Product Quality score of 4 out of 5 stars rated by its users and customers.
Sign Up to unlock Alkermes' overall Product Quality score rated by its users and customers.
Alkermes’s product quality score is a 4 out of 5 as rated by its users and customers.
Compared to its competitors, Alkermes's Product Quality score is rated right above Biogen, and is preceded by Sunovion Pharmaceuticals.
| COMPANY | Product Quality Score | |
|---|---|---|
![]() | Sunovion Pharmaceuticals | 5/5 |
![]() | Alkermes | 4/5 |
![]() | Biogen | 4/5 |
![]() | MyoKardia | 4/5 |
![]() | Alnylam Pharmaceuticals | 3.8/5 |
![]() | Reata Pharmaceuticals | N/A |
![]() | TESARO | N/A |
![]() | Shire | N/A |
Alkermes has a value for money and ROI score of 4 out of 5 stars rated by its users and customers.
Sign Up to unlock Alkermes' overall ROI score rated by its users and customers.
Compared to its competitors, Alkermes's ROI score is rated right above MyoKardia, and is preceded by Sunovion Pharmaceuticals.
| COMPANY | Pricing Score | |
|---|---|---|
![]() | Sunovion Pharmaceuticals | 5/5 |
![]() | Alkermes | 4/5 |
![]() | MyoKardia | 4/5 |
![]() | Biogen | 3.8/5 |
![]() | Alnylam Pharmaceuticals | 3/5 |
![]() | Reata Pharmaceuticals | N/A |
![]() | TESARO | N/A |
![]() | Shire | N/A |
Alkermes has an overall Customer Satisfaction score of 63 rated by its users and customers.
Sign Up to see the full customer demographics data and the people that answered "How would you rate your overall satisfaction with the service you received?"
Customer Satisfaction Score (also known as CSAT), is a metric used to quantify how satisfied customers are with a company or brand’s products and services. The Customer Satisfaction Score is based on customers response to the question: “How would you rate your overall satisfaction with the service you received?” The score is calculated using the formula: (The total number answer of “Very Satisfied” and “Satisfied”) ÷ (The total response) x100, and it is generally displayed in percentages. Some of the main benefits of the CSAT for businesses are tracking retention, identifying happy customers and growing relationships, and gaining repeat business to build a sustainable brand.
Compared to its competitors, Alkermes's Customer Satisfaction score is rated right above MyoKardia, and is preceded by Alnylam Pharmaceuticals.
| COMPANY | Customer Satisfaction (CSAT) Score | |
|---|---|---|
![]() | Sunovion Pharmaceuticals | 100% |
![]() | Biogen | 78% |
![]() | Alnylam Pharmaceuticals | 67% |
![]() | Alkermes | 63% |
![]() | MyoKardia | 0% |
![]() | Reata Pharmaceuticals | 0% |
![]() | TESARO | 0% |
![]() | Shire | 0% |
Alkermes has an overall Customer Service score of 4.2 out of 5 stars rated by its users and customers.
Sign Up to unlock Alkermes' overall Customer Service score rated by its users and customers.
852 winter Street, Waltham, MA 02451
http://www.alkermes.com
(781) 609-6000
Compared to its competitors, Alkermes's Customer Service score is rated right above MyoKardia, and is preceded by Sunovion Pharmaceuticals.
| COMPANY | Customer Service Score | |
|---|---|---|
![]() | Sunovion Pharmaceuticals | 5/5 |
![]() | Alkermes | 4.2/5 |
![]() | MyoKardia | 4/5 |
![]() | Biogen | 3.8/5 |
![]() | Alnylam Pharmaceuticals | 3.3/5 |
![]() | Reata Pharmaceuticals | N/A |
![]() | TESARO | N/A |
![]() | Shire | N/A |
Alkermes has a 4.1/5 stars for its overall company culture rated by their employees

Alkermes scored a 47 for Net Promoter Score and a 15 for Employee Net Promoter Score. NPS gauges how likely a customer of Alkermes would recommend the brand to a friend. ENPS measures how likely Alkermes employees would recommend working at Alkermes to a friend.
| 60% | Promoters |
|---|---|
| 27% | Passive |
| 13% | Detractors |
| 46% | Promoters |
|---|---|
| 23% | Passive |
| 31% | Detractors |